Doxycycline levels in breast milk are generally low, representing a small fraction of the maternal dose. However, potential risks exist, particularly for premature infants and those with underlying health conditions.
Studies show minimal doxycycline transfer to breastfed infants. However, long-term effects of low-level exposure remain largely unknown due to limited research.
The American Academy of Pediatrics suggests considering the benefits of breastfeeding against potential risks when deciding about doxycycline use during lactation. Weighing the severity of the mother’s condition against the potential infant exposure is key.
Close monitoring of the infant for any adverse effects, such as changes in feeding behavior or stool consistency, is advisable. Regular pediatrician visits are recommended during this time.
Alternative antibiotics, with lower breast milk transfer rates, might be considered if the mother’s condition permits. Consult with a healthcare professional to assess individual risks and benefits.
Specific risk factors, such as the infant’s age and pre-existing health issues, should be discussed with a physician to determine the best course of action. This personalized approach ensures the safest outcome for both mother and child.
